Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and DHA in Children with NAFLD
NCT02098317Phase 3Completed
- Start
- Jan 2014
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of docosahexaenoic acid, vitamin d in non-alcoholic fatty liver disease (NAFLD). Started Jan 2014; status: completed.
02
Drugs
docosahexaenoic acidvitamin d
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT02098317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098317.